The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
16 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,038,336 in first-year total cost, median $191,409.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-U (J1)]4
- Special Emphasis Panel[ZCA1 RTRB-R (J2)]2
- Special Emphasis Panel[ZCA1 SRB-5 (M1)]2
- Special Emphasis Panel[ZCA1 SRB-K (M1)]2
- Special Emphasis Panel[ZCA1 RTRB-U (M1)]1
Most frequent institutions
- STANFORD UNIVERSITY2
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- RESEARCH INST OF FOX CHASE CAN CTR1
- SLOAN-KETTERING INST CAN RESEARCH1
- SRI INTERNATIONAL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | (PQ8) Predictive biomarkers for the onset of immune-related adverse events associated with PD-1 blockade1R21CA231277-01A1 | MOR, ADAM | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $262,440 | ZCA1 |
| 2019 | Oncogenic Synapses: cell-cell contacts enabling trogocytic-based metabolic interactions between pancreatic cancer and fibroblastic stromal cells1R21CA231252-01A1 | ASTSATUROV, IGORCUKIERMAN, EDNA | RESEARCH INST OF FOX CHASE CAN CTR, PA | $236,146 | ZCA1 |
| 2019 | Leveraging cancer-specific defects in nuclear integrity to inform novel synthetic lethal strategies1R21CA231269-01A1 | KING, MEGAN CLUSK, CHARLES PATRICK | YALE UNIVERSITY, CT | $218,588 | ZCA1 |
| 2019 | (PQ8) Biomarker identification by mass cytometry in peripheral blood of patients with renal cell carcinoma undergoing immune checkpoint therapy1R21CA231280-01A1 | FANTL, WENDY JANELEPPERT, JOHN THOMAS | STANFORD UNIVERSITY, CA | $205,799 | ZCA1 |
| 2019 | (PQ5) Assessing the contribution of mitochondrial heterogeneity to gliomagenesis using single cell approaches1R21CA227483-01A1 | GAMA, VIVIAN | VANDERBILT UNIVERSITY, TN | $204,885 | ZCA1 |
| 2019 | Altered Histidine Metabolism in Pancreatic Cancer: A Novel Metabolic Target to Enhance Gemcitabine Efficacy1R21CA238953-01 | RACHAGANI, SATYANARAYANAVISWANATHAN, SARASWATHI | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $202,561 | ZCA1 |
| 2019 | Methionine Dependency of Cancer1R21CA242270-01 | KAISER, PETER | UNIVERSITY OF CALIFORNIA-IRVINE, CA | $201,623 | ZCA1 |
| 2019 | Targeting Multiple Colorectal Cancer-Specific Enhancers1R21CA231109-01A1 | PTASHNE, MARK S | SLOAN-KETTERING INST CAN RESEARCH, NY | $195,315 | ZCA1 |
| 2019 | (PQ 12) The Regulation of Physical Function and Skeletal Muscle Metabolic Signaling After Cessation of 5-Fluorouracil Treatment1R21CA231131-01A1 | CARSON, JAMES A | UNIVERSITY OF TENNESSEE HEALTH SCI CTR, TN | $187,502 | ZCA1 |
| 2019 | Microbiota and the anti-tumor action of anti-CD47 immunomodulation.1R21CA231273-01A1 | WEICHSELBAUM, RALPH R | UNIVERSITY OF CHICAGO, IL | $176,175 | ZCA1 |
| 2019 | Understanding Sex Disparities in Gliomas Through Sex Differences in Mitochondrial Activity1R21CA242221-01 | IPPOLITO, JOSEPH EDWARD | WASHINGTON UNIVERSITY, MO | $170,783 | ZCA1 |
| 2019 | The prognostic landscape of gender- and ethnicity-specific immune influences on cancer outcomes1R21CA238971-01 | GENTLES, ANDREW J. | STANFORD UNIVERSITY, CA | $170,194 | ZCA1 |
| 2019 | (PQ5) Mitochondrial Transfer in Tumor Heterogeneity and Acquired Resistence to Therapy1R21CA227480-01A1 | TEITELL, MICHAEL A | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $169,650 | ZCA1 |
| 2019 | Response to PQ12 - Using thiol isomerase inhibitors to diminish cancer induced thrombosis1R21CA231000-01A1 | KENNEDY, DANIEL ROBERTZWICKER, JEFFREY | WESTERN NEW ENGLAND UNIVERSITY, MA | $164,060 | ZCA1 |
| 2019 | Implications of Driver Mutations for Progression of Hepatocellular Carcinoma1R21CA219461-01A1 | GABA, RON CSCHACHTSCHNEIDER, KYLE | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | $139,053 | ZCA1 |
| 2019 | Identification of Synthetic Lethal Partners of Cancer Germline Mutations using Pan-Cancer Human Primary Tumor Data1R21CA231111-01A1 | SHI, YIHUISINHA, SUBARNA | SRI INTERNATIONAL, CA | $133,562 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.1.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.